{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022513","form_type":"8-K","ticker":"DXR","cik":"0000027367","company_name":"DAXOR CORP","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.998755+00:00","generated_at":"2026-05-17T18:33:04.928064+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Daxor receives FDA 510(k) clearance for next-gen blood volume analyzer","bullets":["FDA 510(k) clearance (K251087) for patent-pending rapid, hand-held BVA device.","Device provides results 3x faster, weighs 7 lbs, delivers lab-grade precision.","Clinical data: BVA-guided care reduced heart failure mortality by 86% (p<0.001), ICU mortality by 66%.","Over 75,000 tests shipped; developed under U.S. Army/DHA contract.","Management expects high demand driven by speed, simplicity, precision."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022513","json":"https://secwatch.observer/filing/0001641172-25-022513.json","markdown":"https://secwatch.observer/filing/0001641172-25-022513.md","text":"https://secwatch.observer/filing/0001641172-25-022513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/27367/000164117225022513/0001641172-25-022513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/27367/000164117225022513/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:33:04.928064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}